Targeted Therapy for High-Risk Myeloid Malignancies: Aza+/-Ven in Older AML Disease, Aza/Dec for MDS, Ven+Aza in Treatment-Naïve MDS, Ena/Ivo for IDH-Mutated MPN
Comments 0
Login to view comments.
Click here to Login
